Long Term Incentive Scheme

Futura Medical PLC
07 December 2007




For immediate release                                         7 December 2007


                               Futura Medical Plc
                          ('Futura' or 'the Company')
                           Long Term Incentive Scheme

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative
products for the consumer healthcare market, announces the introduction of a
long term incentive scheme for the Executive Directors under which shares will
be awarded subject to the achievement of key milestone events at the Company.



The Board believes that this Long Term Incentive Scheme ('LTIS'), which has been
developed and reviewed over the past 12 months, is in the interests of all
shareholders as it aligns the interests of the Company's Directors with those of
all other shareholders.



The Executive Directors currently have beneficial interests in 1,062,687 Futura
shares representing 1.8% of the Company's issued share capital and also hold
existing options over 350,000 Futura shares which currently represent 0.6% of
the Company's issued share capital before the introduction of this LTIS. There
have been no new grants of options to Directors since 22 March 2005.



The actual quantum of the awards received by the Executive Directors will depend
on achieving set milestones and the share price at the time relative to targets
set in advance.  As a guide, if all the approved milestones are achieved at the
share price targets over the next 36 months then the additional shares issued in
after tax settlement would be equivalent to approximately 1.3% of the current
share capital. The detailed scheme rules will be available shortly on the
Corporate Governance pages of the Company's website.








For any further information please contact:
Futura Medical plc
James Barder, Chief Executive                        Tel: [phone]
mail to: [e-mail]            www.futuramedical.co.uk


Canaccord Adams                                      Tel: [phone]
Mark Ashurst / Adria Da Breo



For any media enquiries please contact:
Buchanan Communications                              Tel: [phone]
Mark Court / Rebecca Dietrich



Notes



Futura Medical plc



Futura Medical is a pharmaceutical group that develops innovative products for
consumer healthcare.  The Company is developing a portfolio of products and its
strategy is to license their manufacture and distribution to major
pharmaceutical and healthcare groups.



Futura is based in Guildford, Surrey, and its shares trade on the AIM market of
the London Stock Exchange.



www.futuramedical.co.uk


                      This information is provided by RNS
            The company news service from the London Stock Exchange